REDWOOD CITY, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference in New York on Wednesday, November…Read More
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
